FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

900000000000509007: Amerikaans-Engelse taalreferentieset (metadata)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001115012 United States of America English language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001116013 US English en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001117016 United States of America English language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
8203031000146117 Amerikaans-Engelse taalreferentieset (metadata) nl Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT Netherlands NRC maintained module (core metadata concept)
8203041000146113 taalreferentieset voor Amerikaans-Engels nl Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT Netherlands NRC maintained module (core metadata concept)
8203051000146111 Amerikaans-Engelse taalreferentieset nl Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Netherlands NRC maintained module (core metadata concept)


1338128 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
US English Is a English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept) true Inferred relationship Some

Members acceptabilityId
pT1b: Tumor invades submucosa (esophagus) (finding) Preferred (foundation metadata concept)
pT1b: Tumor invades submucosa (stomach) Preferred (foundation metadata concept)
pT1b: Tumor invades submucosa (stomach) (finding) Preferred (foundation metadata concept)
pT1b: Tumor involves both vocal cords (may involve anterior or posterior commissure) with normal mobility (larynx, glottis) Preferred (foundation metadata concept)
pT1b: Tumor involves both vocal cords (may involve anterior or posterior commissure) with normal mobility (larynx, glottis) (finding) Preferred (foundation metadata concept)
pT1b: Tumor involves ipsilateral parietal (mediastinal, diaphragmatic) pleura, with focal involvement of the visceral pleura (thoracic mesothelioma) Preferred (foundation metadata concept)
pT1b: Tumor involves ipsilateral parietal (mediastinal, diaphragmatic) pleura, with focal involvement of the visceral pleura (thoracic mesothelioma) (finding) Preferred (foundation metadata concept)
pT1b: Tumor limited to the iris (more than 3 clock hours in size) (iris) (uveal melanoma) Preferred (foundation metadata concept)
pT1b: Tumor limited to the iris (more than 3 clock hours in size) (iris) (uveal melanoma) (finding) Preferred (foundation metadata concept)
pT1b: Tumor more than 0.5 cm but not more than 1 cm in greatest dimension (breast) Preferred (foundation metadata concept)
pT1b: Tumor more than 0.5 cm but not more than 1 cm in greatest dimension (breast) (finding) Preferred (foundation metadata concept)
pT1b: Tumor more than 4 cm but not more than 7 cm in greatest dimension, limited to the kidney (kidney) Preferred (foundation metadata concept)
pT1b: Tumor more than 4 cm but not more than 7 cm in greatest dimension, limited to the kidney (kidney) (finding) Preferred (foundation metadata concept)
pT1b:Tumor >0.5 cm but <= 1 cm in greatest dimension (breast) Preferred (foundation metadata concept)
pT1b:Tumor >0.5 cm but <= 1 cm in greatest dimension (breast) (tumor staging) Preferred (foundation metadata concept)
pT1c Preferred (foundation metadata concept)
pT1c (IC): Tumor invades one-half or more of the myometrium (TNM category and FIGO stage) (corpus uteri) Preferred (foundation metadata concept)
pT1c (IC): Tumor invades one-half or more of the myometrium (TNM category and FIGO stage) (corpus uteri) (finding) Preferred (foundation metadata concept)
pT1c (IC): Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) Preferred (foundation metadata concept)
pT1c (IC): Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) (finding) Preferred (foundation metadata concept)
pT1c (IC): Tumor limited to one or both tubes with extension onto or through the tubal serosa, or with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (fallopian tube) Preferred (foundation metadata concept)
pT1c (IC): Tumor limited to one or both tubes with extension onto or through the tubal serosa, or with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (fallopian tube) (finding) Preferred (foundation metadata concept)
pT1c - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. Preferred (foundation metadata concept)
pT1c category Preferred (foundation metadata concept)
pT1c category (finding) Preferred (foundation metadata concept)
pT1c1 Preferred (foundation metadata concept)
pT1c1 - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. Preferred (foundation metadata concept)
pT1c2 Preferred (foundation metadata concept)
pT1c2 - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. Preferred (foundation metadata concept)
pT1c3 Preferred (foundation metadata concept)
pT1c3 - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. Preferred (foundation metadata concept)
pT1c: Tumor 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma) Preferred (foundation metadata concept)
pT1c: Tumor 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma) (finding) Preferred (foundation metadata concept)
pT1c: Tumor 2 cm or less in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) Preferred (foundation metadata concept)
pT1c: Tumor 2 cm or less in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding) Preferred (foundation metadata concept)
pT1c: Tumor >1 cm but <= 2 cm in greatest dimension (breast) Acceptable (foundation metadata concept)
pT1c: Tumor limited to the iris with melanomalytic glaucoma (iris) (uveal melanoma) Preferred (foundation metadata concept)
pT1c: Tumor limited to the iris with melanomalytic glaucoma (iris) (uveal melanoma) (finding) Preferred (foundation metadata concept)
pT1c: Tumor more than 1 cm but not more than 2 cm in greatest dimension (breast) Preferred (foundation metadata concept)
pT1c: Tumor more than 1 cm but not more than 2 cm in greatest dimension (breast) (finding) Preferred (foundation metadata concept)
pT1d Preferred (foundation metadata concept)
pT1d - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. Preferred (foundation metadata concept)
pT1mi Preferred (foundation metadata concept)
pT1mi - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. Preferred (foundation metadata concept)
pT1mic category Preferred (foundation metadata concept)
pT1mic category (finding) Preferred (foundation metadata concept)
pT1mic: Microinvasion 0.1 cm or less in greatest dimension (breast) Preferred (foundation metadata concept)
pT1mic: Microinvasion 0.1 cm or less in greatest dimension (breast) (finding) Preferred (foundation metadata concept)
pT1mic: Microinvasion <= 0.1 cm in greatest dimension (breast) Acceptable (foundation metadata concept)
pT2 Preferred (foundation metadata concept)
pT2 (II): Cervical carcinoma invades beyond uterus but not to pelvic wall or to lower third of vagina (TNM category and FIGO stage) (uterine cervix) Preferred (foundation metadata concept)
pT2 (II): Cervical carcinoma invades beyond uterus but not to pelvic wall or to lower third of vagina (TNM category and FIGO stage) (uterine cervix) (finding) Preferred (foundation metadata concept)
pT2 (II): Tumor confined to the vulva or vulva and perineum, more than 2 cm in greatest dimension (TNM category and FIGO stage) (vulva) Preferred (foundation metadata concept)
pT2 (II): Tumor confined to the vulva or vulva and perineum, more than 2 cm in greatest dimension (TNM category and FIGO stage) (vulva) (finding) Preferred (foundation metadata concept)
pT2 (II): Tumor extends outside of uterus but limited to genital structures (ovary, tube, vagina, broad ligaments) (TNM category and FIGO stage) (gestational trophoblast) Preferred (foundation metadata concept)
pT2 (II): Tumor extends outside of uterus but limited to genital structures (ovary, tube, vagina, broad ligaments) (TNM category and FIGO stage) (gestational trophoblast) (finding) Preferred (foundation metadata concept)
pT2 (II): Tumor invades cervix but does not extend beyond uterus (TNM category and FIGO stage) (corpus uteri) Preferred (foundation metadata concept)
pT2 (II): Tumor invades cervix but does not extend beyond uterus (TNM category and FIGO stage) (corpus uteri) (finding) Preferred (foundation metadata concept)
pT2 (II): Tumor invades paravaginal tissues but not to pelvic wall (TNM category and FIGO stage) (vagina) Preferred (foundation metadata concept)
pT2 (II): Tumor invades paravaginal tissues but not to pelvic wall (TNM category and FIGO stage) (vagina) (finding) Preferred (foundation metadata concept)
pT2 (II): Tumor involves one or both fallopian tubes with pelvic extension (TNM category and FIGO stage) (fallopian tube) Preferred (foundation metadata concept)
pT2 (II): Tumor involves one or both fallopian tubes with pelvic extension (TNM category and FIGO stage) (fallopian tube) (finding) Preferred (foundation metadata concept)
pT2 (II): Tumor involves one or both ovaries with pelvic extension AND/OR implants (TNM category and FIGO stage) (ovary) Preferred (foundation metadata concept)
pT2 (II): Tumor involves one or both ovaries with pelvic extension AND/OR implants (TNM category and FIGO stage) (ovary) (finding) Preferred (foundation metadata concept)
pT2 - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. Preferred (foundation metadata concept)
pT2 category Preferred (foundation metadata concept)
pT2 category (finding) Preferred (foundation metadata concept)
pT2 stage Acceptable (foundation metadata concept)
pT2: Melanoma 1.01 to 2.0 mm in thickness, with or without ulceration (melanoma of the skin) Preferred (foundation metadata concept)
pT2: Melanoma 1.01 to 2.0 mm in thickness, with or without ulceration (melanoma of the skin) (finding) Preferred (foundation metadata concept)
pT2: Minimal invasion of the optic nerve and/or optic coats (retinoblastoma) Preferred (foundation metadata concept)
pT2: Minimal invasion of the optic nerve and/or optic coats (retinoblastoma) (finding) Preferred (foundation metadata concept)
pT2: Organ confined (prostate) Preferred (foundation metadata concept)
pT2: Organ confined (prostate) (finding) Preferred (foundation metadata concept)
pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm (liver, including intrahepatic bile ducts) Preferred (foundation metadata concept)
pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm (liver, including intrahepatic bile ducts) (finding) Preferred (foundation metadata concept)
pT2: Tumor > 2 cm but <= 5 cm in greatest dimension (breast) Acceptable (foundation metadata concept)
pT2: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates (maxillary sinus) Preferred (foundation metadata concept)
pT2: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates (maxillary sinus) (finding) Preferred (foundation metadata concept)
pT2: Tumor confluent with or extending into the ciliary body and/or choroid (iris) (uveal melanoma) Preferred (foundation metadata concept)
pT2: Tumor confluent with or extending into the ciliary body and/or choroid (iris) (uveal melanoma) (finding) Preferred (foundation metadata concept)
pT2: Tumor extends to the soft tissues (nasopharynx) Preferred (foundation metadata concept)
pT2: Tumor extends to the soft tissues (nasopharynx) (finding) Preferred (foundation metadata concept)
pT2: Tumor extends to the supraglottis AND/OR subglottis, AND/OR with impaired vocal cord mobility (larynx, glottis) Preferred (foundation metadata concept)
pT2: Tumor extends to the supraglottis AND/OR subglottis, AND/OR with impaired vocal cord mobility (larynx, glottis) (finding) Preferred (foundation metadata concept)
pT2: Tumor extends to vocal cord(s) with normal or impaired mobility (larynx, subglottis) Preferred (foundation metadata concept)
pT2: Tumor extends to vocal cord(s) with normal or impaired mobility (larynx, subglottis) (finding) Preferred (foundation metadata concept)
pT2: Tumor greater than 10 mm but not more than 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) (ciliary body and choroid) (uveal melanoma) Preferred (foundation metadata concept)
pT2: Tumor greater than 10 mm but not more than 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) (ciliary body and choroid) (uveal melanoma) (finding) Preferred (foundation metadata concept)
pT2: Tumor invades beyond the wall of bile duct (extrahepatic bile ducts) Preferred (foundation metadata concept)
pT2: Tumor invades beyond the wall of bile duct (extrahepatic bile ducts) (finding) Preferred (foundation metadata concept)
pT2: Tumor invades duodenal wall (ampulla of Vater) Preferred (foundation metadata concept)
pT2: Tumor invades duodenal wall (ampulla of Vater) (finding) Preferred (foundation metadata concept)
pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of hemilarynx (hypopharynx) Preferred (foundation metadata concept)
pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of hemilarynx (hypopharynx) (finding) Preferred (foundation metadata concept)
pT2: Tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx Preferred (foundation metadata concept)
pT2: Tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx (finding) Preferred (foundation metadata concept)
pT2: Tumor invades muscularis (renal pelvis and ureter) Preferred (foundation metadata concept)
pT2: Tumor invades muscularis (renal pelvis and ureter) (finding) Preferred (foundation metadata concept)
pT2: Tumor invades muscularis propria (appendix) Preferred (foundation metadata concept)
pT2: Tumor invades muscularis propria (appendix) (finding) Preferred (foundation metadata concept)

Start Previous Page 13362 of 13382 Next End


Reference Sets

Reference set descriptor

Back to Start